David Cox, a senior vice president at Pfizer, has died, reports Matthew Herper at Forbes. Cox was 66. As Herper notes, Cox was part of the effort to sequence the human genome, then was the chief scientific officer of Perlegen before moving onto Pfizer where he oversaw genetic research.
"David Cox was a world-renowned geneticist and a highly valued leader here at Pfizer," a company spokesperson said in a statement to Forbes. "As the company's lead geneticist based at our Rinat facility in San Francisco, David was a driving force in shaping Pfizer's strategy on Precision Medicine, as well as our vision for the future of biomedical innovation."